Bangkok Dusit Medical Services PCL (BDUUF)
0.7744
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Bangkok Dusit Medical Services Enterprise Value: 12.30B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 12.30B |
| May 30, 2024 | 12.30B |
| May 29, 2024 | 12.30B |
| May 28, 2024 | 12.30B |
| May 24, 2024 | 12.30B |
| May 23, 2024 | 12.30B |
| May 22, 2024 | 12.30B |
| May 21, 2024 | 12.30B |
| May 20, 2024 | 12.25B |
| May 17, 2024 | 12.25B |
| May 16, 2024 | 12.25B |
| May 15, 2024 | 12.25B |
| May 14, 2024 | 12.25B |
| May 13, 2024 | 12.25B |
| May 10, 2024 | 12.25B |
| May 09, 2024 | 12.25B |
| May 08, 2024 | 12.25B |
| May 07, 2024 | 12.25B |
| May 06, 2024 | 12.25B |
| May 03, 2024 | 12.25B |
| May 02, 2024 | 11.92B |
| May 01, 2024 | 11.92B |
| April 30, 2024 | 11.92B |
| April 29, 2024 | 11.92B |
| April 26, 2024 | 11.92B |
| Date | Value |
|---|---|
| April 25, 2024 | 11.92B |
| April 24, 2024 | 11.92B |
| April 23, 2024 | 11.92B |
| April 22, 2024 | 11.92B |
| April 19, 2024 | 11.92B |
| April 18, 2024 | 11.92B |
| April 17, 2024 | 11.92B |
| April 16, 2024 | 11.92B |
| April 15, 2024 | 11.92B |
| April 12, 2024 | 11.92B |
| April 11, 2024 | 11.92B |
| April 10, 2024 | 11.92B |
| April 09, 2024 | 11.92B |
| April 08, 2024 | 11.92B |
| April 05, 2024 | 11.92B |
| April 04, 2024 | 11.92B |
| April 03, 2024 | 11.92B |
| April 02, 2024 | 11.92B |
| April 01, 2024 | 11.92B |
| March 31, 2024 | 11.92B |
| March 28, 2024 | 12.06B |
| March 27, 2024 | 12.06B |
| March 26, 2024 | 12.06B |
| March 25, 2024 | 12.06B |
| March 22, 2024 | 12.06B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.280B
Minimum
Mar 31 2020
14.42B
Maximum
Jun 07 2023
11.72B
Average
11.95B
Median
Jan 11 2021
Enterprise Value Benchmarks
| Bumrungrad Hospital PCL | 5.165B |
| NewGenIvf Group Ltd | -- |
| CEL-SCI Corp | 60.22M |
| AIM ImmunoTech Inc | 10.88M |
| IGC Pharma Inc | 29.80M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 114.12M |
| Revenue (Quarterly) | 745.46M |
| Total Expenses (Quarterly) | 596.95M |
| EPS Diluted (Quarterly) | 0.0073 |
| Gross Profit Margin (Quarterly) | 37.11% |
| Profit Margin (Quarterly) | 15.31% |
| Earnings Yield | 3.40% |
| Operating Earnings Yield | 4.51% |
| Normalized Earnings Yield | 3.390 |